Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
7.04
+0.07 (1.00%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Zura Bio Employees
Zura Bio had 30 employees as of December 31, 2024. The number of employees increased by 15 or 100.00% compared to the previous year.
Employees
30
Change (1Y)
15
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$2,084,000
Market Cap
667.92M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 579 |
| Replimune Group | 479 |
| Prime Medicine | 214 |
| ProKidney | 204 |
| Vor Biopharma | 154 |
| Theravance Biopharma | 97 |
| Tectonic Therapeutic | 60 |
ZURA News
- 4 days ago - Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress - Business Wire
- 7 days ago - Zura Bio to Participate in Upcoming Investor Conferences - Business Wire
- 10 days ago - Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 12 days ago - Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants - Business Wire
- 13 days ago - Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants - Business Wire
- 14 days ago - Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D. - Business Wire
- 4 weeks ago - Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit - Business Wire
- 6 weeks ago - Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer - Business Wire